LIPOPROTEINS AND ATHEROGENESIS-Reference-Cited by-同舟云学术

LIPOPROTEINS AND ATHEROGENESIS

Published:1998-09 Issue:3 Volume:27 Page:569-584
ISSN:0889-8529
Container-title:Endocrinology and Metabolism Clinics of North America
language:en
Short-container-title:Endocrinology and Metabolism Clinics of North America

Author:

Hoeg Jeffrey M.

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference113 articles.

1. Findings leading to discontinuation of the 2.5-mg day estrogen group: The coronary Drug Project Research Group;The Coronary Drug Project;JAMA,1973

2. Intestinal expression of human apolipoprotein A-IV in transgenic mice fails to influence dietary lipid absorption or feeding behavior;Aalto-Setälä;J Clin Invest,1994

3. Mechanism of hypertriglyceridemia in human apolipoprotein (Apo) CIII transgenic mice: Diminished very low density lipoprotein fractional catabolic rate associated with increased apoCIII and reduced apoE on the particles;Aalto-Setälä;J Clin Invest,1992

4. Further characterization of the metabolic properties of triglyceride-rich lipoproteins from human and mouse apoC-III transgenic mice;Aalto-Setälä;J Lipid Res,1996

5. Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice;Agellon;J Biol Chem,1991

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dietary cholesterol and oxidised cholesterol: effects on sperm characteristics, antioxidant status and hormonal profile in rats;Andrologia;2014-03-12

2. The Rabbit as an Experimental Model;The Laboratory Rabbit, Guinea Pig, Hamster, and Other Rodents;2012

3. Intervalo QT corrigido e fatores de risco tradicionais para doença aterosclerótica em pacientes com diabetes tipo 1;Arquivos Brasileiros de Endocrinologia & Metabologia;2007-10

4. Novel QTLs for HDL levels identified in mice by controlling forApoa2allelic effects: confirmation of a chromosome 6 locus in a congenic strain;Physiological Genomics;2004-03-12

5. Peroxisome proliferator-activated receptor-γ agonists in atherosclerosis: current evidence and future directions;Current Opinion in Lipidology;2003-12